Zhang Lingqiu, Zhang Fan, Liang Haimei, Qin Xiangling, Liang Chunmei, Zhong Manlu, Mo Yuemi, Xie Jinling, Hou Xiaotao, Deng Jiagang, Hao Erwei, Du Zhengcai
Guangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, University Engineering Research Center of Reutilization of Traditional Chinese Medicine Resources, Guangxi University of Chinese Medicine, Nanning 530200, China.
Guangxi Key Laboratory of TCM Formulas Theory and Transformation for Damp Diseases, Institute of Traditional Chinese and Zhuang-Yao Ethnic Medicine, Guangxi University of Chinese Medicine, Nanning 530200, China.
Pharmaceuticals (Basel). 2025 May 30;18(6):824. doi: 10.3390/ph18060824.
Chi (), a traditional Chinese "food and medicine homology" plant, has demonstrated potential anti-tumor properties. However, its mechanisms of anti-lung cancer activity via ferroptosis remain unclear. This study aimed to construct an integrated research system of "natural product extraction-purification, bioactivity evaluation, and computational drug screening" to explore the bioactive compounds in leaves targeting HMOX-1-mediated ferroptosis and their anti-lung cancer mechanisms. Active fractions were prepared using ethanol extraction combined with polyamide column chromatography. The anti-lung cancer activity was evaluated using the NCI-H1975 cell model. Ferroptosis was verified via transmission electron microscopy (TEM), biochemical indicators, a PCR Array, and immunofluorescence. The bioactive compounds were identified using UPLC-Q Exactive MS, and their binding affinity to HMOX-1 was evaluated via molecular docking and dynamics simulations, followed by cellular validation. The 95% F1 fraction from the extracts of leaves exhibited the strongest anti-lung cancer activity, which could be significantly reversed by Ferrostatin-1. Furthermore, it induced typical ferroptosis-related structural damage in mitochondria, including shrinkage and a reduction in size, increased membrane density, and a reduction or even the disappearance of cristae structures. At the molecular level, this fraction significantly increased the levels of oxidative stress markers (ROS↑, MDA↑, Fe↑, and GSH↓) and upregulated the expression of key ferroptosis-related genes, including HMOX-1, CHAC1, and NOX1. Using UPLC-Q Exactive MS combined with computational simulation methods, four bioactive compounds with high affinity for HMOX1 were successfully identified, including isochlorogenic acid A (-8.4 kcal/mol), isochlorogenic acid C (-8.4 kcal/mol), apigenin (-7.8 kcal/mol), and chrysin (-7.3 kcal/mol). Cellular experiments validated that these compounds exhibited dose-dependent anti-proliferative effects. The leaves of induce anti-lung cancer effects via HMOX-1-mediated ferroptosis. Isochlorogenic acid A/C, apigenin, and chrysin were identified as key bioactive components. These findings lay the foundation for the development of natural ferroptosis-targeted drugs.
茈(Chi)是一种中国传统的“药食同源”植物,已显示出潜在的抗肿瘤特性。然而,其通过铁死亡发挥抗肺癌活性的机制尚不清楚。本研究旨在构建一个“天然产物提取-纯化、生物活性评价及计算机辅助药物筛选”的综合研究体系,以探索茈叶中靶向血红素加氧酶-1(HMOX-1)介导的铁死亡的生物活性化合物及其抗肺癌机制。采用乙醇提取结合聚酰胺柱色谱法制备活性部位。使用NCI-H1975细胞模型评价抗肺癌活性。通过透射电子显微镜(TEM)、生化指标、PCR阵列和免疫荧光验证铁死亡。使用超高效液相色谱-四级杆飞行时间质谱(UPLC-Q Exactive MS)鉴定生物活性化合物,并通过分子对接和动力学模拟评估它们与HMOX-1的结合亲和力,随后进行细胞验证。茈叶提取物的95% F1部位表现出最强的抗肺癌活性,铁抑素-1可显著逆转该活性。此外,它还诱导了线粒体中典型的铁死亡相关结构损伤,包括线粒体收缩、体积减小、膜密度增加以及嵴结构减少甚至消失。在分子水平上,该部位显著增加了氧化应激标志物(活性氧↑、丙二醛↑、铁↑和谷胱甘肽↓)的水平,并上调了关键铁死亡相关基因的表达,包括HMOX-1、CHAC1和NOX1。通过UPLC-Q Exactive MS结合计算机模拟方法,成功鉴定出四种与HMOX1具有高亲和力的生物活性化合物,包括异绿原酸A(-8.4千卡/摩尔)、异绿原酸C(-8.4千卡/摩尔)、芹菜素(-7.8千卡/摩尔)和白杨素(-7.3千卡/摩尔)。细胞实验验证这些化合物表现出剂量依赖性的抗增殖作用。茈叶通过HMOX-1介导的铁死亡诱导抗肺癌作用。异绿原酸A/C、芹菜素和白杨素被鉴定为关键生物活性成分。这些发现为开发天然的铁死亡靶向药物奠定了基础。